What medications are recommended for managing restlessness and aggressiveness?

Management of Restlessness and Aggressiveness

For acute agitation and aggression, atypical antipsychotics (haloperidol or second-generation agents like risperidone) combined with benzodiazepines represent the most effective pharmacological approach after verbal de-escalation attempts, with specific agent selection depending on the clinical context and underlying diagnosis. 1, 2

Initial Approach: Non-Pharmacological De-escalation

Before any medication is administered, verbal de-escalation should be attempted unless there is imminent danger requiring immediate intervention. 1, 3

• Engage the patient verbally by exploring concerns, ensuring effective communication, and explaining your role and the situation clearly 2
• Modify the environment by decreasing sensory stimulation, ensuring adequate lighting, removing potential weapons, and eliminating triggers of agitation (such as argumentative individuals or long wait times) 1
• Use calming techniques including speaking in a calm tone, avoiding complex commands or open-ended questions, and maintaining appropriate physical distance 1
• Address reversible causes such as hypoxia, urinary retention, constipation, pain, or medication-induced delirium (lidocaine, atropine, cimetidine, meperidine can all cause agitation) 4, 2

Pharmacological Management by Clinical Context

For Acute Agitation in Emergency Settings (Adults)

First-line combination therapy:

• Haloperidol 0.5-1 mg orally or subcutaneously every 2 hours as needed, with maximum 10 mg daily (5 mg in elderly), combined with 2
• Lorazepam 0.5-1 mg orally or sublingually every 2-4 hours as needed (maximum 4 mg/24 hours; reduce to 0.25-0.5 mg in elderly with maximum 2 mg/24 hours) 2

Alternative for patients unable to swallow:

• Midazolam 2.5-5 mg subcutaneously every 2-4 hours as needed, or continuous infusion starting at 10 mg over 24 hours (reduce to 5 mg/24 hours if eGFR <30 mL/min) 2

For severe delirium with agitation (unable to swallow):

• Levomepromazine 12.5-25 mg subcutaneously as starting dose (6.25-12.5 mg in elderly), then hourly as needed, maintained with 50-200 mg subcutaneous infusion over 24 hours 2

For Children and Adolescents with Agitation

The combination of a benzodiazepine and an antipsychotic is recommended by experts for acutely agitated pediatric patients. 1

• Lorazepam is preferred due to fast onset, complete absorption, and no active metabolites 1
• Atypical antipsychotics (risperidone, olanzapine) are most commonly prescribed for acute and chronic maladaptive aggression 5
• Important caveat: Quetiapine has limited evidence in pediatric chemical restraint due to lack of FDA approval, long onset time, and no injectable formulation 6

For aggression with comorbid ADHD:

• Stimulants or atomoxetine should be first-line, as treating the underlying ADHD often improves oppositional behavior 5

For aggression with conduct disorder:

• Divalproex sodium or lithium carbonate show promise in controlled trials targeting aggressive behavior 5

For Agitation in Dementia Patients

Critical warning: Atypical antipsychotics should NOT be first-line for behavioral symptoms of dementia due to limited efficacy and significant harm potential, including increased mortality risk. 7, 6

Recommended approach:

• Prioritize non-pharmacological interventions including caregiver education, environmental modifications, and addressing unmet needs (pain, hunger, toileting) 7
• If medication necessary after behavioral interventions fail: Consider low-dose risperidone 0.25-0.5 mg daily, but only for severe psychosis or aggression causing imminent harm 7, 8
• Avoid benzodiazepines in elderly due to risk of paradoxical reactions, cognitive impairment, and falls 6

For Agitation in Patients on SSRIs (e.g., Escitalopram)

Atypical antipsychotics are preferred adjunctive agents for SSRI-associated agitation. 9

• Quetiapine 25 mg orally once or twice daily (less likely to cause extrapyramidal symptoms but may cause orthostatic hypotension) 9
• Olanzapine 2.5-5 mg orally or subcutaneously at bedtime (avoid combining with benzodiazepines due to oversedation risk) 9
• Monitor for QT prolongation when combining with escitalopram and check for CYP2D6 drug interactions 9

For Nicotine Withdrawal-Related Agitation

Pharmacological therapy may benefit hospitalized smokers experiencing withdrawal symptoms (restlessness, irritability, anger). 4

• Anxiolytics may be used but require thorough understanding of pharmacokinetics and should not be routine 4
• Psychological support has been shown to decrease anxiety and depression for up to 6 months and is preferred over routine anxiolytic use 4

Critical Monitoring and Safety Considerations

• Establish symptom baseline before starting medications to accurately attribute effects 5
• Monitor for adverse effects closely, including extrapyramidal symptoms, orthostatic hypotension, oversedation, and respiratory depression 1, 9
• Time-limit medication use and attempt dose reduction or discontinuation periodically, as behaviors may resolve over time 7
• Avoid polypharmacy by trying one medication class thoroughly before switching 6
• Never combine high-dose olanzapine with benzodiazepines due to risk of oversedation, respiratory depression, and fatalities 9
• Reduce doses in elderly, renally impaired, or hepatically impaired patients 2, 9

Common Pitfalls to Avoid

• Do not add multiple medications rapidly without assessing response to each change 6
• Do not use psychotropics for behaviors unlikely to respond: unfriendliness, poor self-care, memory problems, inattention, repetitive questioning, care refusal, shadowing, or wandering 7
• Recognize that benzodiazepines can paradoxically worsen agitation in approximately 10% of patients 9
• Remember that no medication has FDA approval specifically for aggression treatment, requiring careful risk-benefit evaluation 5